153 related articles for article (PubMed ID: 22863263)
21. Hepatitis C infection in dialysis patients: a link to poor clinical outcome?
Kalantar-Zadeh K; Daar ES; Eysselein VE; Miller LG
Int Urol Nephrol; 2007; 39(1):247-59. PubMed ID: 17009087
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis C virus infection and dialysis: 2012 update.
Fabrizi F
ISRN Nephrol; 2013; 2013():159760. PubMed ID: 24959533
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies.
Fabrizi F; Martin P; Dixit V; Bunnapradist S; Dulai G
Am J Transplant; 2005 Jun; 5(6):1452-61. PubMed ID: 15888054
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C in dialysis patients.
Polenakovic M; Dzekova P; Sikole A
Prilozi; 2007 Jul; 28(1):239-65. PubMed ID: 17932471
[TBL] [Abstract][Full Text] [Related]
25. Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group.
Pereira BJ; Natov SN; Bouthot BA; Murthy BV; Ruthazer R; Schmid CH; Levey AS
Kidney Int; 1998 May; 53(5):1374-81. PubMed ID: 9573555
[TBL] [Abstract][Full Text] [Related]
26. Clinical characteristics and mortality in hepatitis C-positive haemodialysis patients: a population based study.
Kalantar-Zadeh K; McAllister CJ; Miller LG
Nephrol Dial Transplant; 2005 Aug; 20(8):1662-9. PubMed ID: 15905194
[TBL] [Abstract][Full Text] [Related]
27. Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents.
Grebely J; Raffa JD; Lai C; Kerr T; Fischer B; Krajden M; Dore GJ; Tyndall MW
J Viral Hepat; 2011 Jan; 18(1):32-41. PubMed ID: 20196806
[TBL] [Abstract][Full Text] [Related]
28. Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data.
Johnson DW; Dent H; Yao Q; Tranaeus A; Huang CC; Han DS; Jha V; Wang T; Kawaguchi Y; Qian J
Nephrol Dial Transplant; 2009 May; 24(5):1598-603. PubMed ID: 19096083
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis status and mortality in hemodialysis population.
Santoro D; Mazzaglia G; Savica V; Li Vecchi M; Bellinghieri G
Ren Fail; 2009; 31(1):6-12. PubMed ID: 19142803
[TBL] [Abstract][Full Text] [Related]
30. Seroprevalence of hepatitis C virus and hepatitis B virus among dialysis patients in Bahrain and Saudi Arabia.
Almawi WY; Qadi AA; Tamim H; Ameen G; Bu-Ali A; Arrayid S; Abou Jaoude MM
Transplant Proc; 2004; 36(6):1824-6. PubMed ID: 15350487
[TBL] [Abstract][Full Text] [Related]
31. Epidemiology and clinical significance of hepatotropic infections in dialysis patients. Recent evidence.
Fabrizi F; Bunnapradist S; Lunghi G; Aucella F; Martin P
Minerva Urol Nefrol; 2004 Sep; 56(3):249-57. PubMed ID: 15467503
[TBL] [Abstract][Full Text] [Related]
32. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
33. [Natural history of hepatitis C virus infection in dialysis].
Fabrizi F; Martin P; Lunghi G; Ponticelli C
G Ital Nefrol; 2003; 20(5):470-7. PubMed ID: 14634962
[TBL] [Abstract][Full Text] [Related]
34. Seroprevalence of hepatitis B and C in maintenance dialysis in a public hospital in a developing country.
Otedo AE; Mc'Ligeyo SO; Okoth FA; Kayima JK
S Afr Med J; 2003 May; 93(5):380-4. PubMed ID: 12830604
[TBL] [Abstract][Full Text] [Related]
35. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
Heinz J; Kropf S; Luley C; Dierkes J
Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
[TBL] [Abstract][Full Text] [Related]
36. Antiviral therapy of hepatitis C in chronic kidney diseases: meta-analysis of controlled clinical trials.
Fabrizi F; Ganeshan SV; Lunghi G; Messa P; Martin P
J Viral Hepat; 2008 Aug; 15(8):600-6. PubMed ID: 18444984
[TBL] [Abstract][Full Text] [Related]
37. Multicity study of air pollution and mortality in Latin America (the ESCALA study).
Romieu I; Gouveia N; Cifuentes LA; de Leon AP; Junger W; Vera J; Strappa V; Hurtado-Díaz M; Miranda-Soberanis V; Rojas-Bracho L; Carbajal-Arroyo L; Tzintzun-Cervantes G;
Res Rep Health Eff Inst; 2012 Oct; (171):5-86. PubMed ID: 23311234
[TBL] [Abstract][Full Text] [Related]
38. Effects of concomitant hepatitis C virus infection in patients with underlying lupus nephritis on long-term renal outcome.
Mitwalli AH; Hayat A; Alwakeel J; Hammad D
Nephrol Dial Transplant; 2012 Feb; 27(2):627-32. PubMed ID: 21771749
[TBL] [Abstract][Full Text] [Related]
39. Effect of chronic viral hepatitis on graft survival in Saudi renal transplant patients.
Mitwalli AH; Alam A; Al-Wakeel J; Al Suwaida K; Tarif N; Schaar TA; Al Adbha B; Hammad D
Nephron Clin Pract; 2006; 102(2):c72-80. PubMed ID: 16244496
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
